Drug Reduces the Need for Surgery in Nearly 90% of Patients with HCM, Cleveland Clinic Study Shows

Fri, 29 Aug 2025 12:01:39 +0000

To read more about the VALOR-HCM study, please visit https://cle.clinic/3ti8ExY

Findings from a Cleveland Clinic-led clinical trial, the VALOR-HCM study, showed that the use of mavacamten in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.

To learn more about Dr. Milind Desai, please visit https://cle.clinic/2XvWi51

If you liked the video hit like and subscribe for more!